Pediatric cerebral proliferative angiopathy presenting infratentorial hemorrhage

Manish Beniwal1, Sandeep Kandregula1, Aravind2

  • 1Department of Neurosurgery, NIMHANS, Bangalore, India.

Insights

Cerebral proliferative angiopathies (CPAs) are rare vascular malformations. This report details a rare pediatric case of CPA presenting with cerebellar hemorrhage, managed medically with stable findings.

Area of Science:

  • Neurology
  • Vascular Malformations
  • Pediatric Neurology

Background:

  • Cerebral proliferative angiopathies (CPAs) are distinct vascular malformations, differing from arteriovenous malformations (AVMs).
  • CPAs typically present in young females with seizures, headaches, or neurological deficits; hemorrhage is rare.
  • Pediatric cases of CPA are exceptionally uncommon.

Observation:

  • This case report describes a child diagnosed with CPA who presented with a cerebellar bleed.
  • The child received medical management for the condition.
  • Follow-up imaging at 18 months showed no change in the caliber of the affected vessels.

Findings:

  • The case highlights a rare pediatric presentation of CPA with cerebellar hemorrhage.
  • Medical management was effective in stabilizing the vascular malformation in this pediatric patient.
  • The study reviews existing literature on pediatric CPA presentations and management.

Implications:

  • This case expands the understanding of CPA presentations in pediatric populations.
  • It underscores the potential for medical management in pediatric CPA with hemorrhage.
  • Further research into rare pediatric vascular malformations like CPA is warranted.

Related Concept Videos

Proliferative Phase01:20

Proliferative Phase

The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
263
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
257
Cerebral Hemispheres01:05

Cerebral Hemispheres

The human brain, a complex organ, is functionally divided into two cerebral hemispheres—left and right. These hemispheres are interconnected by a structure of paramount importance, the corpus callosum. This substantial bundle of neural fibers is not just a bridge between the hemispheres but a crucial element for the brain's comprehensive functioning. It enables efficient communication between the two hemispheres, allowing each side of the brain to control and receive sensory and motor...
2.1K